Study of Adverse Events in Fluorescein Angiography Examinations

Comparison of Adverse Events Between Fluorescein Angiography Alone and Combined Fluorescein and Indocyanine Green Angiography - FAvsFA+ICGA Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061506

Enrollment

10000

Registered

2026-06-01

Start date

2026-05-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing fluorescein angiography for retinal and choroidal diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent fluorescein angiography examinations at Nagoya University Hospital between October 1, 2014 and November 18, 2025 Patients whose examination records and adverse event information are available in the electronic medical records and examination logs

Exclusion criteria

Exclusion criteria: Cases in which angiographic examination could not be confirmed from examination records Cases undergoing ICGA alone

Design outcomes

Primary

Measure	Time frame
Incidence of adverse events in the FA alone group and the combined FA+ICGA group	—

Secondary

Measure	Time frame
Rate of examination discontinuation or inability to complete examination Frequency of each type of adverse event Clinical characteristics of patients with discontinued or incomplete examinations Rate of repeat angiographic examinations after adverse events Recurrence rate of adverse events	—

Countries

Japan

Contacts

Public ContactTaishi Imao

Nagoya University Hospital Department of Ophthalmology

imao.taishi.y0@f.mail.nagoya-u.ac.jp052-744-2277

Outcome results